One likely effect of the new US government’s recent actions to disrupt NIH grant funding to US universities has been a hit to stock prices of suppliers of life science instrumentation for university R&D.  The Trump Administration’s actions include restrictions and terminations of grants, as well as delays or cancellations of grant review meetings and […]